Creative Eye Limited (NSE:CREATIVEYE)

Intra-Cellular Therapies Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	24.48	26.08	4.72	19.62	30.79	61.28
Revenue	24.48	26.08	4.72	19.62	30.79	61.28
Revenue Growth (YoY)	665.03%	452.56%	-75.94%	-36.29%	-49.75%	-66.16%
Cost of Revenue	15.34	15.96	18.27	21.07	36.16	22.16
Gross Profit	9.15	10.12	-13.55	-1.45	-5.37	39.12
Selling, General & Admin	-	-	-	-	-	0.17
Other Operating Expenses	8.22	7.62	9.91	1.3	5.83	44.39
Operating Expenses	8.84	8.27	10.65	2.12	6.74	45.7
Operating Income	0.3	1.85	-24.2	-3.58	-12.11	-6.58
Interest Expense	-8.52	-9.03	-8.28	-6.74	-5.96	-4.43
Interest & Investment Income	-	-	6.76	6.67	6.36	8.47
Other Non Operating Income (Expenses)	-	-	-0.28	-0.27	-0.33	-0.21
EBT Excluding Unusual Items	-8.22	-7.18	-26	-3.92	-12.04	-2.74
Gain (Loss) on Sale of Assets	-	-	0.1	0.19	3.04	-
Pretax Income	-8.22	-7.18	-25.9	-3.72	-9	-2.74
Income Tax Expense	-	-	-	-	0.42	-
Net Income	-8.22	-7.18	-25.9	-3.72	-9.42	-2.74
Net Income to Common	-8.22	-7.18	-25.9	-3.72	-9.42	-2.74
Shares Outstanding (Basic)	20	20	20	20	20	20
Shares Outstanding (Diluted)	20	20	20	20	20	20
Shares Change (YoY)	-1.80%	-0.62%	-	-	-	-
EPS (Basic)	-0.41	-0.36	-1.29	-0.19	-0.47	-0.14
EPS (Diluted)	-0.41	-0.36	-1.29	-0.19	-0.47	-0.14
Free Cash Flow	-	-11.21	-18.06	-4.55	-21.47	-6.29
Free Cash Flow Per Share	-	-0.56	-0.90	-0.23	-1.07	-0.31
Gross Margin	37.36%	38.81%	-286.99%	-7.41%	-17.43%	63.84%
Operating Margin	1.23%	7.10%	-512.62%	-18.23%	-39.33%	-10.74%
Profit Margin	-33.58%	-27.51%	-548.68%	-18.98%	-30.60%	-4.48%
Free Cash Flow Margin	-	-42.96%	-382.53%	-23.18%	-69.73%	-10.27%
EBITDA	0.93	2.5	-23.45	-2.75	-11.2	-5.44
EBITDA Margin	3.79%	9.59%	-	-14.03%	-36.38%	-8.88%
D&A For EBITDA	0.63	0.65	0.74	0.82	0.91	1.14
EBIT	0.3	1.85	-24.2	-3.58	-12.11	-6.58
EBIT Margin	1.23%	7.10%	-	-18.23%	-39.33%	-10.74%
Revenue as Reported	33.12	34.84	13.77	39.32	43.7	70.79

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.